Core Viewpoint - Delixi Co., Ltd. is planning a change in control, which may lead to a shift in its major shareholder and actual controller, with the specifics yet to be determined [1] Group 1: Company Overview - Delixi Co., Ltd. was founded in 1996 and listed on the Shenzhen Stock Exchange in 2011, specializing in the research and manufacturing of various glass products, becoming a leading glassware manufacturer in China and ranking third globally in production capacity [1] - The company ventured into the photovoltaic glass market in November 2020 by establishing a wholly-owned subsidiary, Delixi Energy, and signed a five-year procurement agreement with Longi Green Energy on April 20, 2021 [1][2] Group 2: Financial Performance - Following its entry into the photovoltaic sector, Delixi Co., Ltd. has experienced continuous losses, with a net profit loss of over 31 million yuan in 2020, escalating to a loss of 120 million yuan in 2024, and an additional loss of over 45 million yuan in the first half of 2025 [2] - The company's asset-liability ratio surged from 24% in 2019 to 68% in 2024, indicating increasing financial strain [2] - As of September 30, 2025, Delixi Co., Ltd. had a market capitalization of 3.261 billion yuan [4] Group 3: Recent Developments - In 2025, Delixi Co., Ltd. announced the sale of its wholly-owned subsidiary, Delixi Mining, for a total transaction price of 135 million yuan, with the payment already received by September 23 [4]

Core Insights - The article highlights significant fluctuations in the market prices of silver and tin, which have impacted the stock price of Xingye Silver Tin [1] Performance - Chipone Technology expects a record high quarterly revenue of 1.284 billion yuan for Q3 [1] - Great Wall Motors reported a year-on-year sales increase of 23.29% in September [1] - Foton Motor's total vehicle sales in September grew by 6.08% year-on-year, with new energy vehicle sales increasing by 47.77% [1] - BYD experienced a year-on-year decline of 5.52% in new energy vehicle sales in September [1] - Seres saw a year-on-year sales increase of 8.33% in September [1] - BAIC Blue Valley's subsidiary reported a year-on-year sales increase of 30.15% in September [1] - Yonghe Holdings anticipates a year-on-year net profit increase of 211.59% to 225.25% for the first three quarters [1] Shareholding Changes - Huaxing Yuanchuang's shareholders plan to reduce their holdings by no more than 0.9% [1] - Ruile New Materials' shareholders intend to reduce their holdings by no more than 100,800 shares [1] Share Buybacks - Huaxin Cement plans to repurchase shares worth between 32.25 million and 64.5 million yuan [1] Contract Awards - Bomei Technology signed a contract for an offshore floating production storage and offloading vessel project, valued at approximately 190 to 240 million USD [1] - Sichuan Gold acquired exploration rights for the Kugezi-Juebei gold mine in Xinjiang [1] - Weisheng Information won projects totaling 287 million yuan, accounting for 10.45% of the company's expected revenue for 2024 [1] - Innovent Biologics' subsidiary signed a licensing agreement for the drug Orelabrutinib and two preclinical assets, with a total transaction value exceeding 2 billion USD [1] - Runjian Co. plans to bid for a land-based wind power project worth 1.753 billion yuan [1] - Xinjiang Jiaojian intends to bid for a highway construction project valued at 483 million yuan [1] Equity Changes - Delixi Holdings is planning a change in company control, leading to a stock suspension [1] - Bofei Electric plans to transfer 100% equity of its wholly-owned subsidiary Bofei New Energy [1] Other Developments - Dianguang Media holds 4.1288 million shares of Ruili Technology through Dacheng Venture Capital, representing 2.2915% of its post-issue total share capital [1] - Huaxin Cement has terminated plans for a spin-off listing of its overseas subsidiary [1] - Baili Tianheng received approval for clinical trials of BL-ARC001 for late-stage solid tumor treatment [1] - *ST Gaohong received a notice of termination of listing [1] - *ST Jianyi plans to sign an agreement to terminate the investment cooperation for the monocrystalline silicon project and deregister Jianyi Zhengyao [1]

Major Events - Delixi Co., Ltd. is planning a change in control, with stock suspension starting from October 9, 2025, for up to two trading days [1] - Sichuan Gold has won the exploration rights for the Kugez—Juebei gold mine in Xinjiang for 510 million yuan, indicating significant mining potential in a key mineral belt [1] - *ST Gaohong received a notice of termination of listing due to stock prices being below 1 yuan for 20 consecutive trading days [2] - Baili Tianheng's innovative drug BL-ARC001 has received clinical trial approval for treating advanced solid tumors, marking a significant advancement in targeted therapy [3] - Xingye Silver Tin's stock price fluctuation is attributed to significant recent price changes in its main products, silver and tin [3] Performance Overview - BAIC Blue Valley's subsidiary reported a 30.15% year-on-year increase in September sales, totaling 20,539 vehicles [4] - Seres achieved a 19.44% year-on-year increase in September sales, reaching 44,700 new energy vehicles [4] - BYD's September sales of new energy vehicles decreased by 5.52% year-on-year, totaling 396,300 vehicles, with exports of 71,256 vehicles [5] - Chipone Technology expects Q3 revenue of 1.284 billion yuan, a 119.74% increase from the previous quarter and a 78.77% increase year-on-year [5] - Yonghe Holdings anticipates a net profit increase of 448% to 507% for Q3, with projected profits of 456 million to 476 million yuan for the first three quarters [5] Major Contracts - Xinjiang Jiaojian has been awarded a 483 million yuan highway construction project [6] - Longquan Co. is a candidate for a project worth 50.76 million yuan, expected to positively impact revenue and profit [7] - Runjian Co. has secured a design and construction contract for a land-based wind power project valued at 1.753 billion yuan [8] - Innovent Biologics has signed a licensing agreement with Zenas BioPharma for the drug Obrutinib and two preclinical assets, with a total deal value exceeding 2 billion USD [8] Shareholding Changes - Huaxing Yuanchuang announced plans for its employee shareholding platforms to reduce their holdings by up to 0.9% of the company's total shares [9][10]

经公司向深圳证券交易所申请，公司股票(证券简称：德力股份，证券代码：002571)自2025年10月9日 (星期四)开市起停牌，预计停牌时间不超过2个交易日。 格隆汇10月8日丨德力股份(002571.SZ)公布，公司于2025年9月30日收到控股股东及实际控制人施卫东 先生的通知，其正在筹划公司控制权变更事项，具体交易方案、协议条款等尚需进一步论证和磋商，具 体情况届时以各方签订的相关正式交易协议为准。 ...

德力股份（002571）(002571.SZ)发布公告，公司于2025年9月30日收到控股股东及实际控制人施卫东先 生的通知，其正在筹划公司控制权变更事项，具体交易方案、协议条款等尚需进一步论证和磋商，具体 情况届时以各方签订的相关正式交易协议为准。 经公司向深圳证券交易所申请，公司股票自2025年10月9日(星期四)开市起停牌，预计停牌时间不超过2 个交易日。 ...

经公司向深圳证券交易所申请，公司股票自2025年10月9日(星期四)开市起停牌，预计停牌时间不超过2 个交易日。 智通财经APP讯，德力股份(002571.SZ)发布公告，公司于2025年9月30日收到控股股东及实际控制人施 卫东先生的通知，其正在筹划公司控制权变更事项，具体交易方案、协议条款等尚需进一步论证和磋 商，具体情况届时以各方签订的相关正式交易协议为准。 ...

公告显示，公司于2025年9月30日收到控股股东及实际控制人施卫东的通知，其正在筹划公司控制权变 更事项，具体交易方案、协议条款等尚需进一步论证和磋商，具体情况届时以各方签订的相关正式交易 协议为准。 德力股份称，上述事项可能导致公司控股股东及实际控制人发生变更。鉴于上述事项处于筹划阶段，尚 存在重大不确定性，为保证公平信息披露，避免公司股价异常波动，维护广大投资者利益，经公司向深 圳证券交易所申请，公司股票(证券简称：德力股份，证券代码：002571)自2025年10月9日(星期四)开市 起停牌，预计停牌时间不超过2个交易日。 中国经济网北京10月8日讯德力股份（002571）(002571.SZ)今日发布《关于筹划公司控制权变更事项的 停牌公告》。 德力股份表示，停牌期间，公司将根据相关事项进展情况，严格按照相关法律法规的规定和要求履行信 息披露义务，待上述事项确定后，公司将及时发布相关公告并申请公司股票复牌。 ...

北京商报讯（记者 马换换 王蔓蕾）10月8日，德力股份（002571）披露公告称，因筹划公司控制权变更 事项，公司股票自10月9日开市起停牌，预计停牌时间不超过2个交易日。 德力股份表示，公司于9月30日收到控股股东及实际控制人施卫东的通知，其正在筹划公司控制权变更 事项，具体交易方案、协议条款等尚需进一步论证和磋商，具体情况届时以各方签订的相关正式交易协 议为准。上述事项可能导致公司控股股东及实际控制人发生变更。 交易行情显示，9月30日，德力股份股价收涨6.12%，收于8.32元/股，总市值32.61亿元。 ...

Core Viewpoint - Delixi Co., Ltd. is planning a change in control, as notified by its controlling shareholder and actual controller, Shi Weidong, with specific transaction details yet to be determined [1] Company Summary - Delixi Co., Ltd. announced on October 8 that it will suspend trading of its shares starting October 9, 2025, due to the ongoing planning of a change in control [1] - The company’s revenue for the first half of 2025 was entirely derived from the glass and glass products industry, accounting for 100% of its revenue [1] - As of the announcement, Delixi Co., Ltd. has a market capitalization of 3.3 billion yuan [1]

1、公司股票自 2025 年 10 月 9 日（星期四）开市起停牌，预计 停牌时间不超过 2 个交易日。 2、公司控制权变更事项目前处于筹划阶段，尚存在重大不确定 性，敬请广大投资者注意投资风险。 证券代码：002571 证券简称：德力股份 公告编号：2025-044 安徽德力日用玻璃股份有限公司 关于筹划公司控制权变更事项的停牌公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 特别提示： 2025 年 9 月 30 日 特此公告。 安徽德力日用玻璃股份有限公司 董事会 安徽德力日用玻璃股份有限公司（以下简称"公司"）于 2025 年 9 月 30 日收到控股股东及实际控制人施卫东先生的通知，其正在 筹划公司控制权变更事项，具体交易方案、协议条款等尚需进一步论 证和磋商，具体情况届时以各方签订的相关正式交易协议为准。 上述事项可能导致公司控股股东及实际控制人发生变更。鉴于上 述事项处于筹划阶段，尚存在重大不确定性，为保证公平信息披露， 避免公司股价异常波动，维护广大投资者利益，经公司向深圳证券交 易所申请，公司股票（证券简称：德力股份，证券代码：00257 ...